Nima Rezaei

8 ta ish

Tehran University of Medical Sciences

1. Cell death pathways and viruses: Role of microRNAs

   Javid Sadri Nahand, Layla Shojaie, Seyed Amirreza Akhlagh +9

   Sharh maqolaOAOchiq kirish202118 iqtibos

   ABIABI:AkademIndex/2026.other.227141

2. The Cochrane risk of bias assessment tool 2 (RoB 2) versus the original RoB: A perspective on the pros and cons

   Seyed Aria Nejadghaderi, Maryam Balibegloo, Nima Rezaei

   MaqolaOAOchiq kirish20244 iqtibos

   ABIABI:AkademIndex/2026.other.138287

3. Nanocarriers in glioblastoma treatment: a neuroimmunological perspective

   Faezeh Firuzpour, Kiarash Saleki, Cena Aram +1

   Sharh maqola20244 iqtibos

   ABIABI:AkademIndex/2026.other.276494

4. Understanding the tumor microenvironment for effective immunotherapy

   Habib Sadeghi Rad, James Monkman, Majid Ebrahimi Warkiani +4

   Sharh maqolaOAOchiq kirish20203 iqtibos

   ABIABI:AkademIndex/2026.other.051926

5. Targeted therapy strategies against SARS‐CoV‐2 cell entry mechanisms: A systematic review of in vitro and in vivo studies

   Simin Seyedpour, Behzad Khodaei, Amir Hossein Loghman +7

   Sharh maqola20202 iqtibos

   ABIABI:AkademIndex/2026.other.211001

6. Neurological and neuropsychological adverse effects of SARS-CoV-2 vaccines – where do we stand?

   Mohammad Mahdi Aliasin, Niloufar Yazdanpanah, Nima Rezaei

   Sharh maqola20222 iqtibos

   ABIABI:AkademIndex/2026.other.717261

7. Care of patients with inborn errors of immunity in thirty J Project countries between 2004 and 2021

   Hassan Abolhassani, Tadej Avčin, Nerin N. Bahçeciler +89

   MaqolaOAOchiq kirishImmunodeficiency and Autoimmune DisordersFrontiers in Immunology20220 iqtibos

   ABIABI:AkademIndex/2022.article.000318

8. Thinking 2050: Bioengineering of Science and Art

   Nima Rezaei, Amene Saghazadeh, Alejandro Salado +41

   BobInnovation, Sustainability, Human-Machine SystemsIntegrated science20220 iqtibos

   ABIABI:AkademIndex/2022.chapter.000055